Technical Analysis for VYGR - Voyager Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 13.535 5.58% 0.72
VYGR closed up 5.58 percent on Tuesday, November 19, 2019, on 1.11 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical VYGR trend table...

Date Alert Name Type % Chg
Slingshot Bearish Bearish Swing Setup 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Hammer Candlestick Bullish 5.58%
Lizard Bullish Bullish Day Trade Setup 5.58%
Doji - Bullish? Reversal 5.58%
Lower Bollinger Band Walk Weakness 5.58%
Below Lower BB Weakness 5.58%
Down 3 Days in a Row Weakness 5.58%
Lower Bollinger Band Touch Weakness 5.58%

Older signals for VYGR ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Voyager Therapeutics, Inc., a clinical-stage gene therapy company, focuses on the development of treatments for patients suffering from severe diseases of the central nervous system (CNS). The company focuses in the field of adeno-associated virus gene therapy through innovation and investment in vector engineering and optimization, manufacturing, and dosing and delivery techniques. Its pipeline includes VY-AADC01, which is in Phase 1b clinical trials for treatment of Parkinson's disease; and preclinical programs comprise VY-SOD101 for a monogenic form of amyotrophic lateral sclerosis, VY-FXN01 for Friedreich's ataxia, and VY-HTT01 for Huntington's disease, as well as VY-SMN101 for neuromuscular disease. The company has strategic collaborations with Genzyme Corporation and the University of Massachusetts Medical School. Voyager Therapeutics, Inc. was founded in 2013 and is headquartered in Cambridge, Massachusetts.
Medicine Health Manufacturing Gene Therapy Genetics Parkinson's Disease Amyotrophic Lateral Sclerosis Treatment Of Parkinson's Disease Huntington's Disease Sanofi Friedreich's Ataxia Severe Diseases
Is VYGR a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 28.76
52 Week Low 7.76
Average Volume 340,691
200-Day Moving Average 19.4852
50-Day Moving Average 15.6631
20-Day Moving Average 14.5028
10-Day Moving Average 13.8015
Average True Range 0.8174
ADX 28.9
+DI 17.2393
-DI 31.5419
Chandelier Exit (Long, 3 ATRs ) 14.0775
Chandelier Exit (Short, 3 ATRs ) 14.7622
Upper Bollinger Band 16.2698
Lower Bollinger Band 12.7358
Percent B (%b) 0.23
BandWidth 24.367708
MACD Line -0.7177
MACD Signal Line -0.6164
MACD Histogram -0.1013
Fundamentals Value
Market Cap 364.13 Million
Num Shares 26.9 Million
EPS -2.31
Price-to-Earnings (P/E) Ratio -5.86
Price-to-Sales 69.72
Price-to-Book 5.32
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 14.70
Resistance 3 (R3) 14.60 14.11 14.50
Resistance 2 (R2) 14.11 13.81 14.16 14.44
Resistance 1 (R1) 13.82 13.63 13.97 13.92 14.37
Pivot Point 13.33 13.33 13.41 13.38 13.33
Support 1 (S1) 13.05 13.04 13.19 13.15 12.70
Support 2 (S2) 12.56 12.85 12.61 12.63
Support 3 (S3) 12.27 12.56 12.57
Support 4 (S4) 12.37